Avanos Medical (Avanos Medical) Buyback Yield % : 2.90 (As of May. 18, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Avanos Medical Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avanos Medical's current buyback yield was 2.90%.

Avanos Medical Buyback Yield % Historical Data

The historical data trend for Avanos Medical's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avanos Medical Buyback Yield % Chart

Avanos Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buyback Yield %

Get a 7-Day Free Trial

0.22

0.04

0.69

3.61

1.84

Avanos Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buyback Yield %	Get a 7-Day Free Trial															0.32	0.87	3.92	2.39	3.96

Competitive Comparison of Avanos Medical's Buyback Yield %

For the Medical Devices subindustry, Avanos Medical's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avanos Medical's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avanos Medical's Buyback Yield % falls into.

Avanos Medical Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avanos Medical's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-19.1	+	0)	/	1035.689549
	=	1.84%

Avanos Medical's annualized Buyback Yield for the quarter that ended in Mar. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (-9.1	+	0)	*	4	/	919.923631
	=	3.96%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2024) data.

Avanos Medical Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Avanos Medical's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avanos Medical (Avanos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avanos Medical Inc (NYSE:AVNS) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

8HH:Germany

Address

5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004

Website

https://www.avanos.com

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

Executives

Sudhakar Varshney	officer: SVP, Global Supply Chain	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
John Joseph Hurley	officer: Principal Accounting Officer	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Patrick J Oleary	director	31515 BALLANTYNE CORP, C/O SPX CORP, CHARLOTTE NC 28277
Mojirade James	officer: SVP, General Counsel	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Kerr Holbrook	officer: SVP, GM Chronic Care	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Michael Greiner	officer: SVP - Chief Financial Officer	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421
David Edward Ball	officer: SVP - Global Supply Chain	AVANOS MEDICAL, INC., 5405 WINDWARD PKWY, ALPHARETTA GA 30004
William David Haydon	officer: SVP, GM Pain Franchise	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Arjun Ranjan Sarker	officer: Senior VP, International	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Gary Blackford	director	7700 FRANCE AVENUE SOUTH, EDINA MN 55435
Joseph Fralin Woody	director, officer: Chief Executive Officer	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Steven E Voskuil	officer: See Remarks	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John W Wesley	director	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John Raymond Tushar	officer: President, Global Franchises	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004